Integrative and interpretable machine learning framework for early non-invasive detection of clinically significant liver fibrosis - Quiz - MDSpire

Integrative and interpretable machine learning framework for early non-invasive detection of clinically significant liver fibrosis

  • By

  • Dong Cao

  • Junjie Wang

  • Chenxi Hou

  • Jingyu Zeng

  • Baiyue Tian

  • Yuan Liu

  • Xing Luo

  • Jiaxin Tian

  • Mingbo Zhou

  • Pan Li

  • Huilong Fang

  • Ze Liu

  • Zheng Gong

  • June 23, 2026

  • 0 min

Share

Original Source(s)

Integrative and interpretable machine learning framework for early non-invasive detection of clinically significant liver fibrosis

  • by Dong Cao, Junjie Wang, Chenxi Hou, Jingyu Zeng, Baiyue Tian, Yuan Liu, Xing Luo, Jiaxin Tian, Mingbo Zhou, Pan Li, Huilong Fang, Ze Liu, Zheng Gong

  • June 23, 2026

Related Content

Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies

INVA8001, a novel and highly selective chymase inhibitor, ameliorates liver inflammation, fibrosis, and hyperplasia in Mdr2 knockout mice

T cell dysfunction and metabolic disruption in chronic hepatitis C virus infection